CpG-DNA induces bacteria-reactive IgM enhancing phagocytic activity against Staphylococcus aureus infection
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
CpG-DNA triggers the proliferation and differentiation of B cells which results in the increased production of antibodies. The presence of bacteria-reactive IgM in normal serum was reported; however, the relevance of CpG-DNA with the production of bacteria-reactive IgM has not been investigated. Here, we proved the function of CpG-DNA for the production of bacteria-reactive IgM. CpG-DNA administration led to increased production of bacteria-reactive IgM both in the peritoneal fluid and serum through TLR9 signaling pathway. When we stimulated B cells with CpG-DNA, production of bacteria-reactive IgM was reproduced in vitro. We established a bacteria-reactive monoclonal IgM antibody using CpG-DNA stimulated-peritoneal B cells. The monoclonal IgM antibody enhanced the phagocytic activity of RAW 264.7 cells against S. aureus MW2 infection. Therefore, we suggest that CpG-DNA enhances the antibacterial activity of the immune system by triggering the production of bacteria-reactive IgM. We also suggest the possible application of the antibodies for the treatment of antibiotics-resistant bacterial infections.
Abstract
CpG-DNA triggers the proliferation and differentiation of B cells which results in the increased production of antibodies. The presence of bacteria-reactive IgM in normal serum was reported; however, the relevance of CpG-DNA with the production of bacteria-reactive IgM has not been investigated. Here, we proved the function of CpG-DNA for the production of bacteria-reactive IgM. CpG-DNA administration led to increased production of bacteria-reactive IgM both in the peritoneal fluid and serum through TLR9 signaling pathway. When we stimulated B cells with CpG-DNA, production of bacteria-reactive IgM was reproduced in vitro. We established a bacteria-reactive monoclonal IgM antibody using CpG-DNA stimulated-peritoneal B cells. The monoclonal IgM antibody enhanced the phagocytic activity of RAW 264.7 cells against S. aureus MW2 infection. Therefore, we suggest that CpG-DNA enhances the antibacterial activity of the immune system by triggering the production of bacteria-reactive IgM. We also suggest the possible application of the antibodies for the treatment of antibiotics-resistant bacterial infections.
참고문헌 (29)
- Boes M, "Role of natural and immune IgM antibodies in immune responses", Mol Immunol, 37, pp.1141~1149 (2000)
- Casali P, "Structure and function of natural antibodies", Curr Top Microbiol Immunol, 210, pp.167~179 (1996)
- Hjelm F, "Antibody-mediated regulation of the immune response", Scand J Immunol, 64, pp.177~184 (2006)
- Ehrenstein MR, "The importance of natural IgM : scavenger, protector and regulator", Nat Rev Immunol, 10, pp.778~786 (2010)
- Ricci ML, "Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus", J Med Microbiol, 44, pp.475~481 (1996)
- Hustinx W, "Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis", Eur J Clin Invest, 27, pp.1044~1048 (1997)
- Connolly SE, "Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia", J Immunol, 172, pp.1191~1197 (2004)
- Kinoshita M, "Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa", J Immunol, 177, pp.4627~4635 (2006)
- Schwartz JT, "Natural IgM mediates complementdependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum", J Immunol, 189, pp.3064~3077 (2012)
- Brown JS, "The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice", Proc Natl Acad Sci U S A, 99, pp.16969~16974 (2002)
- Alugupalli KR, "The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes", J Immunol, 170, pp.3819~3827 (2003)
- Klinman DM, "CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma", Proc Natl Acad Sci U S A, 93, pp.2879~2883 (1996)
- Krieg AM, "CpG motifs in bacterial DNA trigger direct B-cell activation", Nature, 374, pp.546~549 (1995)
- Deng JC, "CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection", J Immunol, 173, pp.5148~5155 (2004)
- Ishii KJ, "CpG-activated Thy1. 2+ dendritic cells protect against lethal Listeria monocytogenes infection", Eur J Immunol, 35, pp.2397~2405 (2005)
- Mohamed W, "TLR9mediates S. aureus killing inside osteoblasts via induction of oxidative stress", BMC Microbiol, 16, pp.230~ (2016)
- Wu HM, "CpG-ODN promotes phagocytosis and autophagy through JNK", P38 signal pathway in Staphylococcus aureus-stimulated macrophage, 2016, pp.161, 51~59
- Kim TH, "CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies", Sci Rep, 8, pp.16236~ (2018)
- Adem PV, "Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children", N Engl J Med, 353, pp.1245~1251 (2005)
- Neu HC, "The crisis in antibiotic resistance", Science, 257, pp.1064~1073 (1992)
- Schaffer AC, "Vaccination and passive immunisation against Staphylococcus aureus", Int J Antimicrob Agents, 32(Suppl 1), pp.S71~S78 (2008)
- Fattom AI, "Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection : from the lab bench to phase III clinical trials", Vaccine, 22, pp.880~887 (2004)
- Vernachio J, "Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis", Antimicrob Agents Chemother, 47, pp.3400~3406 (2003)
- Zhou ZH, "The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies", Cell Host Microbe, 1, pp.51~61 (2007)
- Hoffman W, "B Cells, Antibodies, and More", Clin J Am Soc Nephrol, 11, pp.137~154 (2016)
- Cole LE, "Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge", Proc Natl Acad Sci U S A, 106, pp.4343~4348 (2009)
- Panda S, "Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria", EMBO J, 32, pp.2905~2919 (2013)
- 박병권, "Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex", BMB Reports, 52(6), pp.397~402 (2019), 생화학분자생물학회[DOI]
- 김대원, "Tat-ATOX1 inhibits inflammatory responses via regulation of MAPK and NF-κB pathways", BMB Reports, 51(12), pp.654~659 (2018), 생화학분자생물학회